HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-islet cell tumor hypoglycemia associated with recurrent carcinosarcoma of the ovary.

AbstractOBJECTIVE:
To describe the first reported case of non-islet cell tumor hypoglycemia (NICTH) associated with carcinosarcoma of the ovary.
METHODS:
We report the clinical course, imaging, and pathologic findings of our patient and review relevant literature.
RESULTS:
A 48-year-old woman had a surgery to remove ovarian masses, which turned out to be carcinosarcoma of the ovary, stage IIIc; however, she declined postoperative adjuvant chemotherapy. Six months later, she became unconscious with severe hypoglycemia. A large pelvic mass was found and thought to represent a recurrence. Serum insulin and C-peptide were undetectable. Morning cortisol was mildly elevated. Thyroid stimulating hormone, amylase, lipase, and renal and hepatic functions were normal. While insulin-like growth factor (IGF)-I was low, IGF-II was inappropriately elevated. Increased IGF-II/IGF-I ratio was suggestive of NICTH in light of the large pelvic tumor. She required frequent meals, dextrose boluses, and continuous infusions, oral prednisone, and glucagon continuous infusion to prevent recurrent hypoglycemic attacks. Chemotherapy with carboplatin and paclitaxel was initiated, and glucose control started to improve. After 4 cycles of the chemotherapy, the tumor regressed substantially and was surgically removed. She had 3 more cycles of postoperative chemotherapy. Although the reported median survival of this aggressive neoplasm is less than 2 years, this patient has been free of recurrent disease and hypoglycemia for 6 years.
CONCLUSION:
This is the first study to report NICTH in a patient with carcinosarcoma of the ovary. Clinicians should be aware of NICTH as a cause of hypoglycemia especially in a patient with a tumor or history of tumor.
AuthorsGotaro Kojima, Keith Y Terada, Nobuyuki Miki, Kinue Miki
JournalEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (Endocr Pract) 2013 Jul-Aug Vol. 19 Issue 4 Pg. e83-7 ISSN: 1934-2403 [Electronic] United States
PMID23512392 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
Topics
  • Carcinosarcoma (diagnosis, drug therapy, metabolism, surgery)
  • Female
  • Humans
  • Hypoglycemia (diagnosis, drug therapy, metabolism, surgery)
  • Insulin-Like Growth Factor I (metabolism)
  • Insulin-Like Growth Factor II (metabolism)
  • Middle Aged
  • Ovarian Neoplasms (diagnosis, drug therapy, metabolism, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: